CYP24 splicing variants are associated with different patterns of constitutive and calcitriol-inducible CYP24 activity in human prostate cancer cell lines

被引:26
作者
Muindi, Josephia R.
Nganga, Alain
Engler, Kristie L.
Coignet, Lionel J.
Johnson, Candace S.
Trump, Donald L.
机构
[1] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14221 USA
[2] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14221 USA
[3] Roswell Pk Canc Inst, Dept Therapeut & Pharmacol, CSJ, Buffalo, NY 14221 USA
关键词
CYP24SNPs; splicing and enzyme activity profile; prostate cancer cell lines;
D O I
10.1016/j.jsbmb.2006.12.060
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
24-Hydroxylase (CYP24) activity modulates in vitro and in vivo calcitriol metabolism and biologic effects. We have investigated, in human PC3, DU145 and LNCaP prostate cancer cell lines, the relationship of CYP24 single nucleotide polymorphisms (SNPs) and splicing and the variable patterns of baseline and calcitriol-inducible CYP24 activity. DU145 cells exhibit baseline CYP24 activity that is further induced by calcitriol. Baseline and inducible CYP24 activity were barely detectable in LNCaP cells. In PC3, baseline CYP24 activity was undetectable but induced by calcitriol. A different pattern of SNPs was identified at positions 24, 46, 146 and 198 in the intron between exons 9 and 10 of CYP24 gene in each cancer cell line. DUI 45 displayed baseline CYP24 splicing between exon 9 and exon 11; splicing was only observed in calcitriol treated LNCaP cells. Untreated PC3 had a mixed picture (splicing and no splicing); only the spliced form was seen after calcitriol treatment. These results demonstrate that calcitriol treatment modulates CYP24 splicing, and suggests that differences in CYP24 splicing are associated with different patterns of CYP24 activity. (c) 2006 Published by Elsevier Ltd.
引用
收藏
页码:334 / 337
页数:4
相关论文
共 12 条
  • [1] Regulation of vitamin D-1α-hydroxylase and-24-hydroxylase expression by dexamethasone in mouse kidney
    Akeno, N
    Matsunuma, A
    Maeda, T
    Kawane, T
    Horiuchi, N
    [J]. JOURNAL OF ENDOCRINOLOGY, 2000, 164 (03) : 339 - 348
  • [2] Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene
    Albertson, DG
    Ylstra, B
    Segraves, R
    Collins, C
    Dairkee, SH
    Kowbel, D
    Kuo, WL
    Gray, JW
    Pinkel, D
    [J]. NATURE GENETICS, 2000, 25 (02) : 144 - 146
  • [3] Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1α and CYP24) in human nonsmall cell lung carcinomas
    Jones, G
    Ramshaw, H
    Zhang, AQ
    Cook, R
    Byford, V
    White, J
    Petkovich, M
    [J]. ENDOCRINOLOGY, 1999, 140 (07) : 3303 - 3310
  • [4] Colon-specific regulation of vitamin D hydroxylases -: a possible approach for tumor prevention
    Kállay, E
    Bises, G
    Bajna, E
    Bieglmayer, C
    Gerdenitsch, W
    Steffan, I
    Kato, S
    Armbrecht, HJ
    Cross, HS
    [J]. CARCINOGENESIS, 2005, 26 (09) : 1581 - 1589
  • [5] Epigenetic regulation of Vitamin D hydroxylase expression and activity in normal and malignant human prostate cells
    Khorchide, M
    Lechner, D
    Cross, HS
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 93 (2-5) : 167 - 172
  • [6] Liarozole acts synergistically with 1α,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity
    Ly, LH
    Zhao, XY
    Holloway, L
    Feldman, D
    [J]. ENDOCRINOLOGY, 1999, 140 (05) : 2071 - 2076
  • [7] RECIPROCAL POSTTRANSLATIONAL REGULATION OF RENAL 1-ALPHA-HYDROXYLASES AND 24-HYDROXYLASES OF 25-HYDROXYVITAMIN-D3 BY PHOSPHORYLATION OF FERREDOXIN - MESSENGER RNA-DIRECTED CELL-FREE SYNTHESIS AND IMMUNOISOLATION OF FERREDOXIN
    MANDEL, ML
    MOORTHY, B
    GHAZARIAN, JG
    [J]. BIOCHEMICAL JOURNAL, 1990, 266 (02) : 385 - 392
  • [8] Altered pharmacokinetics of 1α,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse
    Masuda, S
    Byford, V
    Arabian, A
    Sakai, Y
    Demay, MB
    St-Arnaud, R
    Jones, G
    [J]. ENDOCRINOLOGY, 2005, 146 (02) : 825 - 834
  • [9] Role of 24-hydroxylase in vitamin D3 growth response of OVCAR-3 ovarian cancer cells
    Miettinen, S
    Ahonen, MH
    Lou, YR
    Manninen, T
    Tuohimaa, P
    Syvälä, H
    Ylikomi, T
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (03) : 367 - 373
  • [10] Miller GJ, 1995, CLIN CANCER RES, V1, P997